Market Place
Sourcing Support
All News #Library
Biotech
Eterna Therapeutics Hosts Inaugural Meeting with Advisory Board
26 Feb 2025 //
GLOBENEWSWIRE
Eterna Expands Scientific Advisory Board With New Appointments
28 Jan 2025 //
GLOBENEWSWIRE
Eterna Posts Preclinical Data For ERNA-101 In Ovarian Cancer
14 Jan 2025 //
GLOBENEWSWIRE
Eterna Therapeutics Appoints Dr. Elena To Board Of Directors
09 Jan 2025 //
GLOBENEWSWIRE
Eterna Therapeutics Launches Research on ERNA-101 in Cancer Models
03 Dec 2024 //
GLOBENEWSWIRE
Eterna Therapeutics Announces $1M Stock Repurchase Program
25 Nov 2024 //
GLOBENEWSWIRE
Eterna Therapeutics Completes Financial Restructuring
30 Oct 2024 //
GLOBENEWSWIRE
Eterna To Present On iPSC Line Mimicking B2M Expression At ASGCT
07 May 2024 //
GLOBENEWSWIRE
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award
03 Jan 2024 //
GLOBENEWSWIRE
Eterna Names Sanjeev Luther as President and Chief Executive Officer
20 Dec 2023 //
GLOBENEWSWIRE
Eterna Therapeutics Announces $9.2 Million Convertible Debt & Warrant Financing
14 Dec 2023 //
GLOBENEWSWIRE
Eterna Therapeutics Appoints James Bristol to Board of Directors
01 Nov 2023 //
GLOBENEWSWIRE
Eterna Announces Initiation of Activities for Hypoimmune Pluripotent Cell Line
06 Sep 2023 //
GLOBENEWSWIRE
Eterna Appoints Biopharma Industry Veteran Dorothy Clarke to Board of Directors
05 Sep 2023 //
GLOBENEWSWIRE
Eterna Announces Completion of $8.7 Million of Convertible Debt Financing
18 Jul 2023 //
GLOBENEWSWIRE
Eterna Appoints Brant Binder and Richard Wagner, Ph.D. to Board of Directors
11 Jul 2023 //
GLOBENEWSWIRE
Eterna Appoints Megan Yung as Chief Strategy Officer, General Counsel
24 May 2023 //
GLOBENEWSWIRE
Eterna Acquires Allogeneic Immuno-Oncology Platform from Exacis Biotherapeutics
02 May 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.